Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Submission of daily report in accordance with Regulation 18(i) of the SEBI (Buy-back of Securities) Regulations, 201804-01-2023
04-01-2023
Windlas Biotech Ltd - 543329 - Submission Of Details Of Extinguishment Pursuant To Provisions Of Regulation 21 Read With Regulation 11 Of The SEBI (Buy-Back Of Securities) Regulations, 2018
This is to inform that, pursuant to the provisions of Regulation 21 read with Regulation 11 of the Buy-back Regulations, the Company has completed the extinguishment of 65,316 (Sixty Five Thousand Three Hundred and Sixteen) equity shares bought back under the Buy-back during the period from December 20, 2022 to December 30, 2022. In connection with the same, we are submitting herewith details of extinguishment along with the debit confirmation letter received from the Central Depository Services Limited and Certificate of Extinguishment for your records.03-01-2023
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015.03-01-2023
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Submission of daily report in accordance with Regulation 18(i) of the SEBI (Buy-back of Securities) Regulations, 201802-01-2023
Windlas Biotech Ltd - 543329 - Closure of Trading Window
Please be advised that in accordance with the Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons of the Company, pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015, the Trading Window for dealing in equity shares of the Company shall remain closed from January 1, 2023, till the expiry of 48 hours after the declaration of financial results of the Company for the quarter ending December 31, 2022. The date of the Board Meeting for declaration of the financial results of the Company for the quarter ending December 31, 2022, will be intimated in due course.30-12-2022
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Submission of daily report in accordance with Regulation 18(i) of the SEBI (Buy-back of Securities) Regulations, 201829-12-2022
Windlas Biotech Ltd - 543329 - Submission Of Details Of Extinguishment Pursuant To Provisions Of Regulation 21 Read With Regulation 11 Of The SEBI (Buy-Back Of Securities) Regulations, 2018
Submission of details of extinguishment pursuant to provisions of Regulation 21 read with Regulation 11 of the SEBI (Buy-back of Securities) Regulations, 201826-12-2022
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Submission of daily report in accordance with Regulation 18(i) of the SEBI (Buy-back of Securities) Regulations, 201826-12-2022
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Submission of daily report in accordance with Regulation 18(i) of the SEBI (Buy-back of Securities) Regulations, 201822-12-2022
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201520-12-2022